There was Jerome, a black and tan colored yorkie, held by loving owner Gabriela Viquez.
Viktória Vajda, one of the protesters, said the time for trying to find common ground with Orbán’s government “has passed.”“If we don’t stand up for the rights of minorities and for our own fundamental rights, then who will when they come for us?” she said. “We’ve reached the point where we have to stand up and say, ‘No more’.”
The protests have defied police orders to disperse from bridges and main thoroughfares in Budapest. And in a rare instance of a street protest outside the Hungarian capital, several hundred demonstrators in the eastern city of Miskolc also protested on Tuesday against the law.Orbán, who critics say has eroded Hungary’s democracy and overseen widespread corruption, has in recent years taken aim at the country’s LGBTQ+ community, prohibiting same-sex adoption and — in a 2021 “child protection” law — banning any LGBTQ+ content including in television, films, advertisements and literature that is available to those under 18.As part of the new law, authorities may use facial recognition tools to identify those who attend prohibited events — such as the
, which draws tens of thousands each year — and can issue fines for violators of up to 200,000 Hungarian forints ($545).Orbán’s party is pushing for a constitutional amendment next week that will codify the ban on public LGBTQ+ events. The Hungarian leader has also pledged to introduce new legislation that will ban demonstrators from blocking traffic on bridges and busy roads, arguing the right of assembly and expression cannot override the rights of commuters.
János Stummer, a member of the opposition Momentum party who was at the protest, said that while the ban on Pride was harmful to members of the LGBTQ+ community, the law is also about “Orbán unilaterally, arbitrarily deciding which events can be held in this country and which cannot.”
Orbán’s government argues that it’s protecting children from “sexual propaganda.”Genetic testing companies such as GeneDx have made some headway in screening more people of diverse backgrounds, but inequities remain.
For example, comprehensive data about cystic fibrosis is scarce among African populations – affecting people who live on the continent as well as those who trace their ancestry there.Black cystic fibrosis patients are more likely than their white counterparts to be among the 10% who don’t benefit from modulator therapies.
While there’s little chance of changing market dynamics, researchers said, one solution is to develop “mutation agnostic” gene therapies targeting all patients with a disease. This approach is being tried in diseases of the retina as well as cystic fibrosis.“There’s a huge push to develop these therapies,” said Dr. Garry Cutting of the Johns Hopkins Cystic Fibrosis Center.